XML 28 R15.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Balance Sheet Detail | 6 Months Ended
--- | ---
Apr. 28, 2024
Balance Sheet Detail [Abstract] |
Balance Sheet Detail | Balance Sheet Detail
| April 28, 2024 |  | October 29, 2023
| (In millions)
Inventories |  |  |
Customer service spares | $ | 1,654 |  |  | $ | 1,589 |
Raw materials | 1,722 |  |  | 1,653 |
Work-in-process | 901 |  |  | 997 |
Finished goods |  |  |
Deferred cost of sales | 313 |  |  | 413 |
Evaluation inventory | 462 |  |  | 423 |
Manufactured on-hand inventory | 639 |  |  | 650 |
Total finished goods | 1,414 |  |  | 1,486 |
Total inventories | $ | 5,691 |  |  | $ | 5,725 |
| April 28, 2024 |  | October 29, 2023
| (In millions)
Other Current Assets |  |  |
Prepaid income taxes and income taxes receivable | $ | 223 |  |  | $ | 412 |
Prepaid expenses and other | 1,016 |  |  | 976 |
| $ | 1,239 |  |  | $ | 1,388 |
| Useful Life |  | April 28, 2024 |  | October 29, 2023
| (In years) |  | (In millions)
Property, Plant and Equipment, Net |  |  |
Land and improvements |  |  | $ | 435 |  |  | $ | 393 |
Buildings and improvements | 3-30 |  | 2,255 |  |  | 2,194 |
Demonstration and manufacturing equipment | 5-8 |  | 2,479 |  |  | 2,353 |
Furniture, fixtures and other equipment | 3-5 |  | 786 |  |  | 762 |
Construction in progress |  |  | 780 |  |  | 672 |
Gross property, plant and equipment |  |  | 6,735 |  |  | 6,374 |
Accumulated depreciation |  |  | (3,777) |  |  | (3,651) |
|  |  | $ | 2,958 |  |  | $ | 2,723 |
| April 28, 2024 |  | October 29, 2023
| (In millions)
Deferred Income Taxes and Other Assets |  |  |
Non-current deferred income taxes | $ | 1,928 |  |  | $ | 1,729 |
Operating lease right-of-use assets | 379 |  |  | 370 |
Finance lease right-of-use assets | 91 |  |  | 108 |
Income tax receivables and other assets | 340 |  |  | 345 |
| $ | 2,738 |  |  | $ | 2,552 |
| April 28, 2024 |  | October 29, 2023
| (In millions)
Accounts Payable and Accrued Expenses |  |  |
Accounts payable | $ | 1,457 |  |  | $ | 1,478 |
Compensation and employee benefits | 788 |  |  | 1,024 |
Warranty | 346 |  |  | 332 |
Dividends payable | 331 |  |  | 267 |
Income taxes payable | 363 |  |  | 282 |
Other accrued taxes | 72 |  |  | 65 |
Interest payable | 38 |  |  | 38 |
Operating lease liabilities, current | 87 |  |  | 84 |
Finance lease liabilities, current | 89 |  |  | 102 |
Other | 603 |  |  | 625 |
| $ | 4,174 |  |  | $ | 4,297 |
| April 28, 2024 |  | October 29, 2023
| (In millions)
Other Liabilities |  |  |
Defined and postretirement benefit plans | $ | 122 |  |  | $ | 126 |
Operating lease liabilities, non-current | 260 |  |  | 252 |
Other | 365 |  |  | 336 |
| $ | 747 |  |  | $ | 714 |
Government Assistance We receive government assistance from various domestic and foreign governments in the form of cash grants or refundable tax credits. These arrangements incentivize capital investments and research and development activities. Government incentives generally contain conditions that must be met in order for the assistance to be earned. We recognize the incentives when there is reasonable assurance that we will comply with all conditions specified in the incentive arrangement and the incentive will be received. We record capital expenditure related incentives as an offset to the associated property, plant and equipment, net within our Consolidated Condensed Balance Sheets and recognize a reduction to depreciation expense over the useful life of the corresponding acquired asset. We record incentives related to operating activities as a reduction to expense in the same line item on the Consolidated Condensed Statements of Operations as the expenditure for which the grant is intended to compensate. Capital expenditure related incentives reduced gross property, plant and equipment, net by $232 million as of April 28, 2024. Contra-depreciation expense was not material during the three and six months ended April 28, 2024. Operating incentives recognized as a reduction to research, development and engineering expense were $6 million and $22 million in the three and six months ended April 28, 2024, respectively. Capital expenditure related incentives reduced our income taxes payable by $112 million as of April 28, 2024, of which $105 million is in accounts payable and accrued expenses and $7 million is in income taxes payable, in our Consolidated Condensed Balance Sheets.

X
- Definition Balance Sheet Detail [Abstract] + References No definition available. + Details
Name: | amat_BalanceSheetDetailAbstract
Namespace Prefix: | amat_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration